Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Launched by THE FOUNDATION FOR ORTHOPAEDICS AND REGENERATIVE MEDICINE · Nov 29, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at the safety and effectiveness of a new treatment using stem cells taken from umbilical cords to help with Peyronie's disease, erectile dysfunction (ED), and interstitial cystitis. The researchers will test how these stem cells can be delivered either through an intravenous (IV) method or directly into the affected area. The goal is to see if this treatment can improve symptoms for people dealing with these conditions.

To be eligible for the trial, participants must have a diagnosis of Peyronie's disease, ED, or interstitial cystitis and be willing to sign a consent form to participate. Some people may not qualify if they have certain health issues, like active infections, cancer, or serious organ problems. If you decide to participate, you can expect to receive the stem cell treatment and be monitored for any side effects. This trial is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of Peyronie's Disease, erectile dysfunction, or Interstitial Cystitis
• • Understanding and willingness to sign a written informed consent document
• Exclusion Criteria:
• • Active infection
• • Active cancer
• • Chronic multisystem organ failure
• • Pregnancy
• • Clinically significant Abnormalities on pre-treatment laboratory evaluation
• • Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
• • Continued drug abuse
• • Pre-menopausal women not using contraception
• • Previous organ transplant
• • Hypersensitivity to sulfur